Letrozole (L) with bevacizumab (B) is feasible in patients (pts) with hormone receptor-positive metastatic breast cancer (MBC) Meeting Abstract


Authors: Traina, T. A.; Rugo, H.; Caravelli, J.; Yeh, B.; Panageas, K.; Bruckner, J.; Norton, L.; Park, J.; Hudis, C.; Dickler, M.
Abstract Title: Letrozole (L) with bevacizumab (B) is feasible in patients (pts) with hormone receptor-positive metastatic breast cancer (MBC)
Meeting Title: 42nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 24
Issue: 18 Suppl. Pt. 1
Meeting Dates: 2006 Jun 2-6
Meeting Location: Atlanta, GA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2006-06-01
Start Page: 133S
Language: English
ACCESSION: WOS:000239009400522
PROVIDER: wos
Notes: --- - Meeting Abstract: - 42nd Annual Meeting of the American-Society-of-Clinical-Oncology - JUN 02-06, 2006 - Atlanta, GA - S - Part 1 - "Source: Wos"
MSK Authors
  1. Clifford Hudis
    848 Hudis
  2. Larry Norton
    581 Norton
  3. Maura N Dickler
    238 Dickler
  4. Tiffany A Traina
    154 Traina
  5. Katherine S Panageas
    331 Panageas
  6. Julia Park
    8 Park